TABLE 5.
Comparison of serum, saliva, and cervical mucus IgA1 and IgG antibody levels to N. gonorrhoeae MS11 and infecting isolates in patients with cervical infections and patients with cervical and rectal infections
Sample | Ig isotype | Visit | Median antibody level (% of total Ig) (range [n])
|
|||
---|---|---|---|---|---|---|
Anti-MS11 antibodies
|
Anti-cervical isolate antibodies
|
|||||
Cervical infection | Cervical and rectal infection | Cervical infection | Cervical and rectal infection | |||
Cervical mucus | IgA1 | 1 | 0.00 (0.00–0.21 [11]) | 0.16 (0.00–0.45 [6]) | 0.00 (0.00–0.08 [12]) | 0.00 (0.00–0.15 [6]) |
IgA1 | 2 | 0.03 (0.00–1.12 [7]) | 0.00 (0.00–0.07 [6]) | 0.07 (0.00–1.97 [7]) | 0.08 (0.00–0.73 [6]) | |
IgG | 1 | 0.57 (0.00–12.40 [11]) | 0.85 (0.41–1.55 [6]) | 0.09 (0.00–0.94 [11]) | 0.32a (0.08–2.43 [6]) | |
IgG | 2 | 0.74 (0.03–2.90 [7]) | 0.71 (0.00–0.86 [5]) | 0.00 (0.00–0.07 [7]) | 0.37b (0.01–1.39 [5]) | |
Saliva | IgA1 | 1 | 0.06 (0.00–0.42 [7]) | 0.04 (0.00–0.09 [5]) | 0.01 (0.00–0.07 [8]) | 0.00 (0.00–0.03 [6]) |
IgA1 | 2 | 0.03 (0.00–0.24 [5]) | 0.03 (0.01–0.05 [4]) | 0.01 (0.01–0.20 [5]) | 0.01 (0.00–0.02 [5]) | |
IgG | 1 | 0.12 (0.00–1.58 [8]) | 0.30 (0.00–0.40 [5]) | 0.26 (0.00–1.91 [8]) | 0.06 (0.00–0.46 [6]) | |
IgG | 2 | 0.47 (0.00–1.77 [5]) | 0.00 (0.00–0.59 [3]) | 0.15 (0.00–4.30 [5]) | 0.00 (0.00–0.43 [5]) | |
Serum | IgA1 | 1 | 0.01 (0.00–0.02 [12]) | 0.02 (0.01–0.05 [7]) | 0.01 (0.00–0.06 [12]) | 0.01 (0.00–0.09 [7]) |
IgA1 | 2 | 0.01 (0.00–0.02 [7]) | 0.02 (0.01–0.05 [6]) | 0.01 (0.01–0.02 [7]) | 0.01 (0.00–0.08 [6]) | |
IgG | 1 | 0.25 (0.14–1.41 [12]) | 0.28 (0.20–1.13 [7]) | 0.21 (0.06–3.42 [12]) | 0.77 (0.00–0.94 [7]) | |
IgG | 2 | 0.28 (0.13–0.58 [7]) | 0.33 (0.25–1.29 [6]) | 0.25 (0.19–0.85 [7]) | 0.46 (0.08–0.79 [6]) |
P = 0.0782 compared with patients with cervical infection.
P = 0.0303 compared with patients with cervical infection.